The U.S. Food and Drug Administration (FDA) has approved Kalydeco (ivacaftor) as the first-ever therapy to treat the underlying cause…
Articles by Marta Figueiredo, PhD
A therapy whose developers say could revolutionize the battle against antibiotic-resistant lung infections in cystic fibrosis patients eliminated resistant Staphylococcus aureus in a…
One of the most frequently mutated genes in cancer, PTEN, in involved in the repeated lung infections that trouble cystic…
Sevion Therapeutics and Eloxx Pharmaceuticals announced that a first healthy subject has been dosed in a Phase 1b clinical…
Cystic fibrosis (CF) patients have more bacteria but lower bacterial diversity in their lungs than people without CF — yet…
Scientists at the University of North Carolina (UNC) School of Medicine developed a model of cystic fibrosis (CF) that may help…
Italian researchers have discovered a molecule that prevents cystic fibrosis patients’Â anti-inflammatory and anti-bacterial defenses from working as well as they…
The European Union’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for…